Evaluating the Use of a Remote Telehome Monitoring Hypertension Program for Patients Receiving Virtual Care

NCT05300503 | Completed

• 1 other identifier: 20210851-01H
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

High blood pressure or hypertension (HTN) is very common and can lead to serious health issues and even death. Medications and lifestyle changes can be used to treat HTN. During the Coronavirus Disease-19 (COVID-19) pandemic, a lot of the care provided by doctors has become virtual, meaning that patients can be assessed by a doctor over the phone or video call without needing to go to a clinic or hospital. Although this is convenient, a lot of people cannot get their blood pressure (BP) checked in a reliable way when they are at home. As a result, it is possible that their BPs are too high and that they are not getting the right medications or the right doses of medications to treat this. The Investigators are performing this study to see how patients are managing to check their BP's at home, during this time when a lot of the care is virtual. The Investigative team understands that many patients diagnosed with HTN don't have a home BP cuff, or might not know how to properly use it, or might not share the results with their doctors. In people who have high BP, we want to see if a special BP cuff and special monitoring program can help to get their BP's under better control, and to prevent negative effects related to HTN.

Conditions

Hypertension

Outcome Measures

Primary Outcomes (2)

• Current state of blood pressure control in virtual settings

  To document the status of blood pressure control (both systolic and diastolic) in virtual hypertension care settings.

  3 months

• Blood pressure response

  Our primary outcome, which is the 24-hour ABPM, will be used to measure BP response in the control \& intervention group at baseline \& after 3-months of the intervention. We will repeat the 24-hour ABPM at 6-months follow up (3-months after completion of the intervention) to assess if there is maintenance of the intervention effects over time. Both systolic and diastolic measurements will be assessed.

  3 months

Study Arms (2)

Control

NO INTERVENTION

Participants will be asked to continue their usual day to day activities and take their current medications as directed. They will be sent a link by email or through MyChart to the standard video \& education session on managing hypertension. They will watch the video at home on their own time. Participants will use a home blood pressure monitor to track their blood pressure (those without a blood pressure cuff will be provided one) for the 3-month intervention period. Patients will be provided instructions of when they should seek medical attention (clinical symptoms or SBP \<100 or SBP \>160). They will be encouraged to track their blood pressure daily and any symptoms they may be feeling.

Intervention

EXPERIMENTAL

Participants will be asked to continue their usual day to day activities and take their current medications as directed. They will be sent a link by email or through MyChart to the educational session described above in the control group section. They will receive an Aetonix aTouchAway platform monitor, which is a disease specific home monitoring device to take home for 3 month intervention period. The device will prompt the participant to check their blood pressure on a daily basis and will send all readings to the UOHI Telehome monitoring program. The telehome monitoring nursing team will monitor the readings for each participant. For hypertensive patients who are not at target with their BP, the telehome monitoring nurse will titrate medications based on an advanced medical directive every 2 weeks. Patients will be provided instructions of when they should seek medical attention (clinical symptoms or SBP \<100 or SBP \>160).

Behavioral: Telehome Monitoring

Interventions

Telehome Monitoring BEHAVIORAL

Participants are enrolled into the Telehome Monitoring program

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Have a diagnosis of primary, essential HTN (SBP\>140/90mmHg or \>130/80mmHg for diabetes)
• Have access to a phone (can be a landline)
• Have access to cellular (4G) network at their primary residence (they do not need to physically own a cellular phone but the need to be able to confirm their residence has 4G network access in order to connect the Aetonix aTouchAway platform to the network)
• Speak English or French

You may not qualify if:

• Patients who have been referred or who are actively managed at a specialized HTN clinic or other Telehome monitoring program
• Women who are pregnant, breastfeeding or planning to become pregnant
• Patients who are institutionalized at a retirement home, nursing home or long-term care facility
• Patients who plan on travelling out of the country for more than 2 weeks at any point during the intervention phase of the study (first 3 months)
• Patients who are cognitively impaired or experiencing acute psychiatric illness that would alter their ability to participate

Sponsors & Collaborators

• Ottawa Heart Institute Research Corporation: lead

Study Sites (1)

The University of Ottawa Heart Institute

Ottawa, Ontario, K1Y4W7, Canada

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Study Officials

• Hassan Mir, MD

  Ottawa Heart Institute Research Corporation

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Participants will be randomly assigned in a 1:1 fashion to either the control group or intervention group.

Study Record Dates

• First Submitted: March 18, 2022
• First Posted: March 29, 2022
• Study Start: August 4, 2022
• Primary Completion: October 31, 2025
• Study Completion: January 31, 2026
• Last Updated: May 6, 2026

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)